CannBioRx Life Sciences Corp (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $5.38 Millions.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, CannBioRx Life Sciences Corp reported $- in revenue, generating net income of $-4.10 Millions.
Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.
The company trades under the ticker ATNFW.